title: Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway.
abstract: MicroRNA-21 (miR-21) is overexpressed virtually in all human cancers and displays oncogenic activity in a transgenic murine model. Similarly, the p53 tumor suppressor gene is the most frequently mutated gene in human cancer, and its loss or mutation leads to tumor formation in mice. To ascertain the role of miR-21 in the p53 pathway in vivo and to characterize their interaction in tumorigenesis, we intercrossed the miR-21 (-/-) and Trp53 (-/-) mice. We found that Trp53 (-/-) miR-21 (-/-) mice develop tumors at a slightly later age, yet show a similar tumor spectrum and survival curve as Trp53 (-/-) mice. When subjected to genotoxic agents, tissues from Trp53 (-/-) miR-21 (-/-) mice have a higher percentage of apoptotic cells. We extracted mouse embryonic fibroblast cells (MEFs) to examine the impact of miR-21 loss on p53-regulated cellular processes in Trp53 (-/-) cells. Higher cellular apoptosis and senescence were found in Trp53 (-/-) miR-21 (-/-) MEFs than in Trp53 (-/-) MEFs. In addition, loss of miR-21 sensitizes transformed Trp53 (-/-) cells to DNA damage-induced apoptosis through elevation of Pten expression. These data suggest that inhibition of miR-21 would be beneficial in apoptosis-inducing cancer therapies directed against p53-deficient tumors.
authors: Department of Biochemistry and Molecular Biology, School of Medicine, University of Louisville, 319 Abraham Flexner Way, Louisville, KY 40202, USA.
authors: Xiaodong
authors: X
authors: Ma
authors: Saibyasachi N
authors: SN
authors: Choudhury
authors: Xiang
authors: X
authors: Hua
authors: Zhongping
authors: Z
authors: Dai
authors: Yong
authors: Y
authors: Li
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects* / Q000235:genetics; D002453:Cell Cycle / Q000235:genetics; D049109:Cell Proliferation / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D016922:Cellular Senescence / Q000235:genetics; D004249:DNA Damage; D004195:Disease Models, Animal; D004317:Doxorubicin / Q000494:pharmacology; D005347:Fibroblasts / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D051059:PTEN Phosphohydrolase / Q000096:biosynthesis; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D000903:Antibiotics, Antineoplastic; C531950:MIRN21 microRNA, mouse; D035683:MicroRNAs; D016159:Tumor Suppressor Protein p53; D004317:Doxorubicin; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse
references: FEBS Lett. 2011 Jan 21;585(2):402-8
references: 21187093
references: Cancer Genet Cytogenet. 2010 Jul 15;200(2):154-60
references: 20620599
references: Int J Cancer. 2007 Sep 1;121(5):1156-61
references: 17487835
references: Cell. 2004 Dec 17;119(6):861-72
references: 15607981
references: Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10144-9
references: 21646541
references: Oncogene. 2004 Jan 29;23(4):973-80
references: 14749764
references: Nature. 1992 Mar 19;356(6366):215-21
references: 1552940
references: Cancer Res. 2009 Oct 15;69(20):8157-65
references: 19826040
references: Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15840-5
references: 21896753
references: Nature. 2007 Feb 8;445(7128):661-5
references: 17251932
references: PLoS One. 2011 Mar 09;6(3):e17850
references: 21408027
references: Nature. 2009 Jul 23;460(7254):529-33
references: 19626115
references: Cell Death Differ. 2011 Jun;18(6):974-84
references: 21233845
references: Nat Biotechnol. 2001 Oct;19(10):971-4
references: 11581665
references: Genes Dev. 2009 Apr 1;23(7):862-76
references: 19293287
references: Cancer Cell. 2010 Sep 14;18(3):282-93
references: 20832755
references: Oncogene. 2013 Aug 22;32(34):4001-8
references: 22964638
references: Cold Spring Harb Perspect Biol. 2010 Jul;2(7):a001180
references: 20595398
references: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12085-90
references: 19597153
references: Breast Cancer Res Treat. 2012 Feb;131(3):1049-59
references: 22057972
references: Cancer Cell. 2011 Nov 15;20(5):635-48
references: 22094257
references: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9
references: 20308559
references: Mol Cell. 2001 Aug;8(2):317-25
references: 11545734
references: Nat Rev Cancer. 2007 Mar;7(3):165-8
references: 17332760
references: Cancer Cell. 2004 Aug;6(2):171-83
references: 15324700
references: Oncogene. 2007 Apr 26;26(19):2799-803
references: 17072344
references: Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12885-90
references: 18728182
references: Cancer Cell. 2002 Apr;1(3):289-98
references: 12086865
references: J Cell Sci. 2003 Oct 15;116(Pt 20):4077-85
references: 12972501
references: Mol Cell Biol. 2009 Mar;29(5):1222-34
references: 19103758
references: Genes Dev. 2004 Feb 1;18(3):320-32
references: 14744934
references: Gastroenterology. 2007 Aug;133(2):647-58
references: 17681183
references: Carcinogenesis. 2010 Aug;31(8):1311-8
references: 20097732
references: Biochem Biophys Res Commun. 2009 Jun 5;383(3):280-5
references: 19302977
references: J Biol Chem. 2008 Jan 11;283(2):1026-33
references: 17991735
references: Mol Cell. 2010 Jun 11;38(5):689-99
references: 20542001
references: Chin J Cancer. 2011 Jun;30(6):371-80
references: 21627859
references: Blood. 2007 Jun 1;109(11):4944-51
references: 17327404
references: Genes Dev. 1991 Dec;5(12B):2375-85
references: 1752433
references: Nature. 2007 Jun 28;447(7148):1130-4
references: 17554337
references: Cancer Res. 2005 Jul 15;65(14):6029-33
references: 16024602
references: Sci Rep. 2012;2:434
references: 22666537
references: Nature. 2007 Feb 8;445(7128):656-60
references: 17251933
references: Cell. 2006 Dec 29;127(7):1323-34
references: 17182091
references: Nature. 2000 Nov 16;408(6810):307-10
references: 11099028
references: Hematology. 2010 Aug;15(4):215-21
references: 20670480
references: Arch Med Res. 2011 May;42(4):281-90
references: 21820606
references: Nature. 2010 Sep 2;467(7311):86-90
references: 20693987
references: Curr Biol. 1994 Jan 1;4(1):1-7
references: 7922305
references: Cancer Res. 2008 Oct 1;68(19):8164-72
references: 18829576